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Chapter 5
Morphometric Studies
   Pathological  investigations  have  consistently  reported  that  brains  of  HD 
patients are markedly smaller than those of matched controls; this has largely 
been attributed to the amounts of cell death in these brains (see Figure 1.1 on 
page  7).   This  idea  was  facilitated  by  the  fact  that  most  postmortem  tissue 
available was from very end stage patients in which most neurons had indeed 
died or were in stages of pronounced cell death.  Therefore it had always been 
assumed  that the  size of  the  brains was  smaller  as  there were  less  neurons 
present,  however with  the  advent  of  the  mouse  models  of the  disease it is 
possible to investigate further this theory.
  In the initial studies carried out on the R6 lines of mice there was very little cell 
death  reported,  but  the  body weights  and  brain  weights  were  found  to  be 
dramatically reduced in the transgenic animals when compared to the controls.
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Figure 5.1:  Graph showing the percentage change in the body weight and brain weights of 
R6/2 mice compared with littermate controls.  What is particularly interesting is that the brain 
weight changes precedes that of the body weight and is apparent at 6 weeks of age when there 
are no overt symptoms in these mice.  Changes in body weight are seen to  occur at 8 weeks 
which is when symptoms are ﬁrst observed.
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6  This morphometric analysis of cell soma and nucleus sets out to investigate 
whether this may indeed be an alternative pathological phenomenon at work, 
one  which  has  been  overlooked  in  human  studies  in  the  past  and  the 
signiﬁcance of which remains to be fully understood.
5.1. Mangiarini/Bates Transgenic R6 Models
  As hypothesised both the R6 lines investigated in this study showed degrees of 
shrinkage  or  reduced  cell  somal  areas  suggesting  that  there  was  some 
pathology  present,  what  would  be more  interesting however,  would  be the 
time-point at which this can ﬁrst be observed and whether this is a signiﬁcant 
method of ascertaining the health of the neuron.  As observed in the stages of 
inclusion formation in Chapter 3 (see Figure 3.2.) there is a steady shrinkage of 
both the cell membrane and the nuclear membrane with the increase in size of 
the inclusion, these analyses appear to be conﬁrming these earlier ﬁndings.
  The R6/2 line of mice showed dramatic shrinkage of the cortical and striatal 
neurons with age, with some but not as dramatic shrinkage in the Purkinje cells.   
This observed shrinkage in the somal areas of neurons may explain the overall 
shrinkage in brain size and some extent of the disease phenotype exhibited by 
these  mice.   The  decrease  in  somal  areas  of  the  three  different  neuronal 
populations sampled in this study can be seen graphically in the ﬁgure overleaf.
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Figure 5.2:   Photographs  below  showing the superior (left) and inferior (right) aspects of 
three control brains (top row) and three R6/2 brains underneath, note how much smaller the 
R6/2 brains are even at this gross level.                                                                                                                                         Results❧
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Figure 5.3:  Graphs showing all the somal areas for different neuronal populations in the R6/2 
brain.  For numbers of animals, cells and nuclei measured please see section 2.5 on page 52 in 
Methods chapter. ˒˒˒ -denotes p<0.001 Student’s t-test indicating a highly signiﬁcant change 
between the somal areas of the R6/2 and littermate control.  As the initial disease progression study showed in Mangiarini et al. Cell paper 
there are several  key landmark events shown in  the timeline.   Those with a 
morphometric relevance ﬁrst occur at 4 weeks of age when it is ﬁrst noted that 
the transgenic mice and their LMCs appear to be diverging in both the cortical 
and  striatal  neurons, this  coincides with  the ﬁrst divergence in brain weight 
reinforcing the idea that an important  pathological event  is occurring at  this 
time-point.  In the time before this both the transgenes and their LMCs show an 
increase in somal areas, this is due to the normal maturation of the brain.
  The cortical somal areas peak at 2 weeks of age and the striatal somal areas 
peak at 3 weeks this coincides with the formation of microaggregates or loci of 
proteins in the nucleus, stage 3 in the inclusion characterisation scale.   These 
loci can be seen with EM48 antibody as a ring of 4 to 6 very small inclusions.
  Overt symptoms begin at around 7 to 8 weeks of age when several proteins are 
present in the nucleus in the form of a large intranuclear inclusion and body 
weight has started  to drop considerably too.   In both the cortex and striatum 
there is approximately 50% shrinkage in the somal areas.  The shrinkage is very 
striking in the cortex perhaps this is because they are larger to begin with.
  From 8 weeks onwards the difference between the transgenes and their LMCs 
widens with somal areas shrinking down to almost a third of the LMCs.  Brain 
and  body  weights  decrease steadily  too with  increasingly severe symptoms.   
The inclusion continues  to increase  in size throughout this end phase of the 
disease.
  The Purkinje cells show a peak in somal  area at 4  weeks after which  they 
appear  to  steadily  decline  and  follow  a  similar  pattern  to  the  cortical  and 
striatal neurons.  Shrinkage does not appear to be very pronounced even at 12 
weeks it is less than 50%.  At 8 weeks there is some divergence between the 
transgenes and their LMCs.   The one thing that does seem a little unusual is 
that the transgene areas are slightly larger in the initial brain maturation period.   
However this may tie in with the observations made at EM microscopy where 
the Purkinje cells of the cerebellum are seen to be very different in their mode of 
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and striatal neurons.  Striatal and cortical cell death in these mice occurs via the 
mechanism of dark cell  degeneration (Turmaine et al. 2000) whereas Purkinje 
cells  seem  to  additionally  explode  similarly  to  necrosis  with  a  large  glial 
response to clear up after the event.  
  The nuclear areas measured in the striatal neurons of R6/2 mice at 4, 8, 10, 12, 
13 and  17 weeks  of age appeared  to show  that the nucleus is  attempting to 
maintain itself by means of increasing nuclear membrane and invaginating and 
so keeping changes in area to a minimum thereby keeping nuclear functions 
intact for as long as possible.  Measurements were only taken in striatal neurons 
as  they could  be compared  to  those  in  the  HD80  model  which  also shows 
striatal  pathology  unlike  the  HD94  model  which  appears  to  behave 
anomalously  by  having  mainly  cortical  pathology  and  very  little  striatal 
pathology.
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Figure  5.4:   Graph  showing  the  nuclear 
areas,  perimeters  and  the  area/perimeter 
ratios  for the striatal  neurons  in the R6/2 
model.  For numbers of animals and nuclei 
measured please see section 2.5 on page 52 
in Methods chapter.
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m  At 4 to 10 weeks of age in the R6/2 model  the areas and perimeters of the 
nucleus appear to be stable and not much change in their values is seen, the 
resultant  area  perimeter ratios  are  also stable  which  suggests  that  the mere 
presence of the inclusion is not the direct cause of these changes.  Perhaps when 
the inclusion  reaches a certain  size such as at around  10 weeks of age these 
changes are instigated.  It appears that both areas and perimeters of this model 
are compromised at around 10 weeks of age when pathology and symptoms 
have set in, after this time point there are more marked changes which show an 
attempt  to  maintain  nuclear  integrity.    These  changes  are  by  no  means 
comparative to the control values which suggests that the attempts to maintain 
nuclear  area  in  order  to  carry  out  vital  processes  are  unsuccessful  and 
eventually succumb to the diseased state and impending cell death.  However 
this presented data does show convincingly that there is a concerted effort on 
the part of the neuron to keep the nucleus functioning as the somal areas are 
shrinking  to  almost  a  thin  rim  around  it,  a  dysfunctional  cell  is  clearly 
preferable to a dead one.
   The R6/1  line  showed  similar patterns  of  morphometric  change  in  somal 
areas.  The cortical areas increase steadily to peak at 4 months after which there 
is  a decline down to about 60% of the control  somal area.   The striatal  areas 
increase and peak at 3 months after which there is a decline down to just under 
50% of the control somal areas.  The Purkinje cell also follow a similar pattern to 
the striatal  neurons with  somal  areas peaking at 3  months  and then show a 
marked decrease of 50%.  The overall pattern of change is similar to the R6/2 
line with  a  longer time period  of months  instead  of  weeks making  it  more 
subtle in the R6/1 line, with not such a dramatic reduction and divergence from 
the LMCs.   As  the phenotype of these mice is not as aggressive pathological 
events appear to take longer to occur.  This is what would be expected, as the 
major difference between the two lines studied is the CAG repeat size that has 
been  inserted  into the construct.   The  weekly  intervals of the  R6/2 line  are 
found to be roughly equivalent to the monthly intervals of the R6/1 mice.  
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Figure 5.5:  Graphs showing all the somal areas for the different neuronal populations in the 
R6/1 brain.  For numbers of animals, cells and nuclei measured please see section 2.5 on page 
52 in  Methods chapter.  ˒˒˒  -denotes  p<0.001  Student’s  t-test  indicating a  highly signiﬁcant 
change between the somal areas of the R6/1 and littermate control.
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Control somal area  As with the R6/2 model the R6/1 also shows changes in the nucleus, both the 
areas and perimeters increase from 12 to 12.5 months of age to become more in 
line with those seen in the LMCs.  The interesting point in these graphs is the 
much more pronounced perimeter changes seen in comparison to the control 
suggesting that nuclear membrane invagination is taking place to maintain the 
nuclear areas (see Figure 1.8 in the introduction Chapter 1 for photographs of 
this phenomenon).  As the pathology is taking place over a longer time frame 
perhaps we can see these changes more clearly than in the R6/2 model.  As seen 
also in the R6/2 model there does appear to be some nuclear remodeling in an 
attempt to maintaining the nuclear integrity by limiting the changes in these 
parameters.  The success of these is more difﬁcult to gauge as these models are 
of an extremely aggressive form of the disease.
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Figure 5.6:  Graphs showing nuclear areas perimeters and area/perimeter ratios for striatal 
neurons in R6/1 model.  For numbers of animals and nuclei measured please see section 2.5 on 
page 52 in Methods chapter.
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  The HD94  model  did not follow  the same  morphometric pattern of somal 
areas seen in the R6 lines of mice.  Most unexpectedly the HD94 mice showed 
an increase in  somal  area in both  cortical  and striatal  neurons,  showing cell 
swelling instead of shrinkage (see Figure 5.7 overleaf) as observed in the two R6 
lines also studied.  The HD94 mice show some symptoms and some pathology 
though it is never as severe as seen in the R6 lines.  It could be that as these mice 
have  neurite  inclusions  as  opposed  to  nuclear  inclusions,  their  transport 
systems are disrupted causing a build up in the cell soma.  Or the expansion of 
the dendritic arbor is taking place in order to reconnect where there has been 
damage.  These mice also exhibit more cell death than the R6 lines suggesting 
that dysfunctioning  neurons pose a  more  deleterious effect than  a relatively 
inert aggregate in the nucleus.  The NII versus the DNI question is discussed in 
more detail in the discussion chapter.
  The DOX treated mice sit comfortably in between the HD94 and their LMCs 
showing that the DOX does appear to inﬂuence any somal changes and any 
possible reversal  of symptoms.   In  the Purkinje cells there appears  to be no 
major difference between the various treated mice at all, this is due to the cam 
kinase  promoter  being inactive  in  the  hindbrain,  leaving  this  population  of 
neurons  completely  unaffected  and  therefore  a  very  good  built  in  control.   
There appears to be slight change in the graphs in the Figure 5.7, however when 
these are taken in context with other neuronal populations in Figure 5.10 these 
appear  to be less  pronounced.   However  what  it  very  apparent  from  these 
somal area studies is that this model does behave very differently to the others 
in the study which all show degrees of shrinkage whereas this model  clearly 
has no such pathology but quite the opposite.
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HD94 model brain at  36 weeks  of  age.   For  numbers  of  animals, cells and nuclei measured 
please see section 2.5 on page 52 in Methods chapter.  ˒˒˒-denotes p<0.001 Student’s t-test 
indicating  a  highly 
signiﬁcant  change 
between  the  somal 
areas  of  the  HD94 
and the HD94 +DOX 
and  the  littermate 
control.
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HD94 model  Nuclear changes in this model appear to be struggling to keep up with those 
seen  in  the  control,  contrary  to the  ﬁndings  in  somal  areas  there  does  still 
appear to be a shrinkage effect in the nucleus albeit a small one.  Additionally 
the changes appear to be most pronounced in the HD94, slightly alleviated in 
the +DOX animals with the control values being larger in all parameters which 
suggests that there is some pathology at the nuclear level however not as acute 
as  in  the other models  studied.   The  area  perimeter ratios summarise  these 
changes well  and emphasise that the changes seen  are ultimately only small 
changes, which corresponds with there being a limited  amount of symptoms 
and pathology in this particular model which surprisingly consistent with other 
models.  These ﬁndings show furthermore that although the somal changes are 
quite  different  the  nuclear  changes  can  be  similar  and  therefore  perhaps 
independent phenomena.  
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Figure 5.8:  Graphs showing nuclear areas perimeters and area/perimeter ratios for striatal 
neurons in HD94 model at 36 weeks of age.  For numbers of animals and nuclei measured 
please see section 2.5 on page 52 in Methods chapter.
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m5.3. Shelbourne knock in mice
  The somal areas in these mice are again very distinct from the previous two 
models in that there is no apparent swelling effect as seen in the HD94 model 
but a very subtle shrinkage effect in mainly the striatal neurons reminiscent of 
that seen in the R6/2 model.   The morphometric study investigated  both the 
full-length and the fragment incorporated mice and it appears that the fragment 
has  a more potent  effect on the somal  areas of  cortical  and  striatal  neurons 
whereas the full-length affects the Purkinje cells more.  As mentioned earlier the 
cortical  neurons  and  Purkinje cells  are  not  as  affected  and  appear  to  be the 
similar to the LMCs in this model.
  The variant types of the HD80 model were interesting to compare as it was 
thought previously as the R6 lines were also due to a truncated integration that 
perhaps the HD80 truncated version would also express a similar phenotype, 
which they do to a degree.  However in this parameter it appears that the effect 
was more complex than previously thought with there being a similar effect to 
the R6 model shrinkage effect in the cortex and striatum but not in the Purkinje 
cell population of the cerebellum.  In the R6 models the Purkinje cell pathology 
does appear to be more pronounced after that seen ﬁrst in the cortex followed 
by neurons of the striatum, the HD80 seems not to follow the same pattern of 
pathology  with  the  striatum  being  the  main  event  followed  by  the  cortical 
pathology.
  The striatal speciﬁc shrinkage ties in nicely with the pathology, which is also 
only  observed  in  this  region  of  the  brain  with  very  little  seen  in  the  other 
secondary regions seen in the other two models also investigated in this study.   
This pathology is perhaps not as accurate as that seen in the human brain where 
there is substantial decrease in size in the cortex and Purkinje cells as well as the 
primary  site  of  pathology  in  the  striatum.   It  could  be  that  the  disease 
progression is slowed down too much and the lifespan of the mouse is too short 
to express the complete phenotype observed in human patients.
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HD80 model brain at 36 months of age.   For numbers of animals, cells and nuclei measured 
please see section 2.5 on page 52 in Methods chapter.  ˒˒˒-denotes p<0.001 Student’s t-test 
indicating  a  highly 
signiﬁcant  change 
between  the  somal 
areas  of  the  HD80 
incorporating the full 
length  and  fragment 
construct  and  the 
littermate control.
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˒˒˒  The striatal  nuclear changes  part  of  the study in  this  model  yielded  some 
interesting results.  The incorporated fragment version of the HD80 model had 
a more pronounced reduction in nuclear area with the full-length version not 
apparently exhibiting as  much, however the perimeters  tell  a different story 
with  the  full  length  having  a  much  greater  increase  in  perimeter  than  the 
fragment and the control.  These ﬁndings would suggest that both the fragment 
and  to  a  greater  extent  the  full  length  HD80  nuclei  are  showing  similar 
pathology  to  the  R6  models  with  there  being  some  evidence  for  nuclear 
membrane  invagination  and  remodelling  in  order  to  maintain  the  nucleus.   
These results even out in the area perimeter ratios which show the full length to 
have the most nuclear pathology followed by the fragment model.  However it 
must  be  noted  that  the  y  axes  of  the  graphs  have been  expanded  and  the 
changes are in fact quite small but there nonetheless.
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Nuclear areas of striatal neurons in the HD80 model
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Figure  5.10:    Graphs  showing  nuclear  areas, 
perimeters  and area/perimeter ratios for striatal 
neurons in HD80 model at 36 months of age.  For 
numbers of animals and nuclei measured please 
see section 2.5 on page 52 in Methods chapter.5.4. Summary of results
  The comparative graphs are useful to show the summary of the morphometric 
analysis of the somal  areas in all  three of the models.   The most pronounced 
shrinkage in the R6/2 model is seen in the cortex, being more than 50%, closely 
followed by the striatum and Purkinje cells of the cerebellum.  The HD94 model 
shows  marked  swelling  in  the  striatum  and  less  so  in  the  cortex,  with  the 
Purkinje cells being unaffected.  The administering of DOX alleviates this effect 
and shows only some swelling, not as pronounced as in the HD94 animals.  The 
HD80 model shows the fragment to cause a more marked shrinkage effect in 
the striatum  and  cortex,  but  the full-length  to have  more  of  an effect on the 
Purkinje cell  population, suggesting that they may be following different cell 
death pathways thus behaving very differently.  The control measurements are 
fairly close and suggest that a certain amount of shrinkage occurs naturally as 
an artefact of ageing, the older animals in this study namely from the HD94 and 
more so of the HD80 models tend to show a more prominent of ageing effect.
  The phenomenon that is highlighted very dramatically is the aggressive nature 
of  the  disease in  the R6/2  model  and  the  evident  devastating  pathology  it 
causes.   There is a striking difference at the end stage between the transgenic 
and the control animals, more so than either of the other two models and hardly 
any shrinkage due to an ageing effect.  Also remarkable is the passive disease 
progression  in  the  HD80  model  and  the  interesting ﬁndings  of  swelling  as 
opposed to shrinkage in the conditional model, the HD94.  The variation in the 
pathology observed in these models is truly remarkable considering that they 
are constructed from similar genetic constructs which can yield such differing 
results in this one parameter of morphometry.  What does become increasingly 
apparent  is  that  the  state  of  health  of  these  mice  is  correlated  with  the 
morphometric results it appears that the more severely affected the mouse the 
more shrinkage is seen in the corresponding neurons, and seemingly normal 
mice have very subtle shrinkage in their neurons. 
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R6/2, HD94 and the HD80 models.  For numbers of animals, cells and nuclei measured please 
see section 2.5 on page 
52 in Methods chapter.   
˒˒˒-denotes  p<0.001 
Student’s  t-test 
indicating  a  highly 
signiﬁcant  change 
between  the  somal 
areas  of  the  various 
murine models  of  HD 
and  their  littermate 
controls.
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of which  were most  unexpected.   The R6  models  showed  that  with  disease 
progression  there  is  a  shrinkage  effect  followed  by  a  recovery,  this  is 
hypothesised to be the nuclear membrane invagination phenomenon ﬁrst seen 
in the R6/2 model.  The overall changes seen in both the HD94 and the HD80 
models were very subtle changes which could easily be missed in the summary 
graphs, the interesting point about both these models is that despite their somal 
areas  doing  very  different  things,  expanding  in  the  case  of  the  HD94  and 
shrinking in that of HD80, the nuclear changes appear to be the same.   This 
would suggest that these two morphometric parameters are not interdependent 
and that the maintenance of these areas are managed separately by the neuron.   
The  decrease in somal  area  is  not  causative of  the decrease in  nuclear  area 
clearly the cellular actions of mutant htt have implications on both.
  As the neuron strives to maintain the nucleus at any cost the changes seen 
within it are often late in the disease progression, changes in the soma though 
are more signiﬁcant in the light of both symptoms and pathology.  However 
this  is not indicative in any way of the amount of cell death that is present, 
which  in  turn  appears  not  to be indicative of the  state  of  the health  of the 
neuronal  population  and  consequently  symptoms  exhibited.   Therefore  this 
study has shown that  somal  areas  are a  good indicator  of  the  health of the 
neuron and in turn the extent of disease progression, more so than even the 
inclusion itself perhaps.
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